about
Management of Adverse Events During the Treatment of Chronic Hepatitis C Infection.Personalized management of hepatocellular carcinoma based on molecular information: future prospects.Hepatitis A: The Changing Epidemiology of Hepatitis A.Surveillance for Cholangiocarcinoma in Patients with Primary Sclerosing Cholangitis: Effective and Justified?Microbiome in NAFLD and ALDMolecular Epidemiology of Hepatocellular Carcinoma.The Role of the Hepatopathologist in the Assessment of Drug-induced Liver Injury.Microbiome-Immune Interactions and Liver Disease.Schistosomiasis: Clinical management of liver diseaseAcute-on-chronic liver failure: Is the definition ready for prime time?Hepatitis E: The endemic perspectiveA framework to determine when liver transplantation is futileExamination of the abdomenA simple clinical calculator for assessing cardiac event risk in liver transplant candidates: The cardiovascular risk in orthotopic liver transplantation scoreDiagnostic challenges of nonalcoholic fatty liver disease/nonalcoholic steatohepatitisRole of iron in hepatocellular carcinomaBenign and malignant hepatocellular lesions in patients with vascular liver diseaseSocial determinants in liver transplantationPredicting clinical outcome in a patient with chronic hepatitis B virus infectionStatins and metformin for chemoprevention of hepatocellular carcinomaManagement of an acute variceal bleeding episode.Overlap syndrome: A real syndrome?Management of hepatic encephalopathy as an inpatientPathology primer: Common liver biopsy findings in patients who have recently undergone liver transplant or resectionCommon problems in liver allograft biopsy interpretation: Resolving clinical dilemmasBacterial infections in cirrhosis: A growing problem with significant implicationsRelationship between systemic hemodynamics, renal dysfunction, and fluid retention in cirrhosisIgG4-related sclerosing cholangitisGranulomas of the liverBiomarkers of liver fibrosisLiver fibrosis: Which mechanisms matter?Strategies for management of pediatric cystic fibrosis liver diseasePro: The Abstinence Period Should Be the Same for All Patients Undergoing Evaluation for TransplantManagement of nosocomial spontaneous bacterial peritonitis: A complex and moving targetAnticoagulación en la trombosis de la vena porta en la cirrosisBursting with symptoms: A review of palliation of ascites in cirrhosisAnticoagulation for portal vein thrombosis in cirrhosisAssessing the risk of bleeding and clotting in cirrhosisManagement of disordered hemostasis and coagulation in patients with cirrhosisApproach to Hyponatremia in Cirrhosis
P1433
Q35082620-1839AE9F-738F-4B92-95C7-F2271F8C220DQ35881575-E7879BCA-60A0-4378-8AA5-E68706E5082CQ36269365-82DC763C-4E31-4456-AA4A-5F7F54C1288BQ41677917-CB804615-26CD-4988-8521-9FCC4A9C244AQ41864308-E32F161A-DF81-4A8A-BB77-115DA476C404Q41881227-22524E16-7FF6-43EB-8A95-E03BDE114FDFQ49865653-11D345AE-47C4-4454-A66A-940CF1FE8A1DQ55032301-1148343D-0ECA-49A5-AF5D-25F80409A469Q56639210-37A0ABEA-FA9F-405D-9795-92AFEAB659E3Q56925213-129B9A3B-BBBD-42D2-BE36-09E26965A8A2Q57071509-FF45B241-0293-467E-8A6C-7E8C4B3B90E1Q57302157-78D41560-F7A9-4A6F-B990-49FDE3E97009Q57405616-9B64CA3F-2590-4509-93F4-55C8E893688AQ57465021-D0AD3BD8-C504-4A82-8D12-6A21D198BD04Q57465026-2BA7D845-6B94-401D-BF83-91715F14B7E2Q57659795-CAD7FDCA-2BA4-43A7-AF25-83AF15F31D0CQ57782445-A3FBE6DE-44A0-4268-8C44-6F0D86D7FB73Q57817617-AF9F80E4-887C-45BC-995C-E4CB33377A4FQ58814417-365661EE-9695-41EE-8A56-F919578CB82DQ59150549-0BAC05DE-7B2C-45FD-8AD0-F56F9741C067Q59288248-A752144A-9C09-41EC-AE17-A9197328DFA5Q59384428-819182BE-2FFA-41F5-94F2-AD694D303041Q60198879-E5837529-DE9B-44F2-8C71-FD16E8DDD5C4Q61053419-23AB9A4E-1ACF-4068-B775-31719D95276EQ61053422-4E462D41-D4F7-47B6-B046-B1117FE6156DQ61574961-515D2BF8-AF5C-4942-A2DA-07EE7F2A64FCQ61575021-9214AAF0-27A7-457C-B950-8349BFCA1177Q62476915-6D091044-6276-4A1C-A727-57FFC34C3D13Q62476925-94A14E62-B00A-4A4A-A0D5-E791F735B984Q62626273-A39A43E8-9D95-439B-AA18-E4418620C213Q62734673-720453E0-5DDF-4D07-8533-F8C71974D233Q63247975-413C78C3-56AA-4B3E-B134-8D0C38D9FBDBQ63976652-57E69A53-A0CA-4A93-A66D-B3E3650D1F60Q63977664-9669BCFF-0065-4D46-8010-9005EE9CF60FQ63978904-C9BED522-0509-4A30-A691-BD1EEB2E4760Q63979030-E3D8F720-18C9-4FF6-9AA7-ADD1149A01ACQ63979056-A04CF877-F854-489B-A6CA-DC14D3A94791Q63979158-5BA1FFC6-E722-41D6-942F-A9BF077CAD52Q63980059-36D01535-D7AB-4179-8ABB-D9C5859CC97FQ64078098-097F2840-46FD-49A9-9FB0-8FB3B5D72FFD
P1433
description
journal
@en
revista científica
@es
wetenschappelijk tijdschrift van Wiley-Blackwell
@nl
wissenschaftliche Fachzeitschrift
@de
name
Clinical liver disease
@ast
Clinical liver disease
@en
Clinical liver disease
@es
Clinical liver disease
@nl
type
label
Clinical liver disease
@ast
Clinical liver disease
@en
Clinical liver disease
@es
Clinical liver disease
@nl
altLabel
Clin Liver Dis (Hoboken)
@en
prefLabel
Clinical liver disease
@ast
Clinical liver disease
@en
Clinical liver disease
@es
Clinical liver disease
@nl
P3181
P1055
P1156
21100254589
P123
P1476
Clinical liver disease
@en